SCHEMBL13629865

SCHEMBL13629865

CC(=O)CN1C(=O)CCCC1=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
TSHR P16473 2/20 0.39
LMNA P02545 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 3/20 0.36
ALOX12 P18054 1/20 0.36
HPGD P15428 1/20 0.36
GAA P10253 1/20 0.35
CA12 O43570 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
CA3 P07451 1/20 0.35
CA4 P22748 1/20 0.35
CA6 P23280 1/20 0.35
CA5A P35218 1/20 0.35
CA7 P43166 1/20 0.35
CA9 Q16790 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5091798 0.91 TSHR (0.44) POLBMEN1KMT2ATSHRLMNA
SCHEMBL12133543 0.81 POLB (0.37) POLBTSHRLMNASMN1; SMN2RAB9A
SCHEMBL13696923 0.81 TSHR (0.36) POLBMEN1KMT2ATSHRLMNA
SCHEMBL14009883 0.80 POLB (0.55) POLBKMT2ATSHRSMN1; SMN2RAB9A
SCHEMBL4600179 0.79 TSHR (0.52) POLBMEN1KMT2ATSHRLMNA
SCHEMBL15925412 0.78 POLB (0.60) POLBMEN1KMT2ALMNASMN1; SMN2
SCHEMBL6388213 0.77 TSHR (0.59) POLBMEN1KMT2ATSHRLMNA
SCHEMBL7765751 0.77 TSHR (0.39) POLBMEN1KMT2ATSHRLMNA
SCHEMBL11981356 0.77 TSHR (0.36) POLBMEN1KMT2ATSHRLMNA
SCHEMBL14009881 0.74 HTR1A (0.39) POLBTSHRLMNAALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7622487-B2 Piperidine derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-24 US disclosed
US-7622487-B2 Piperidine derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-24 US disclosed
US-20070149570-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-06-28 US disclosed
US-20070149570-A1 Piperidine derivative and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070149570-A1 Piperidine derivative and use thereof TACR1, OPRL1, TRPV1 POLB 4713/4885MEN1 1880/4885KMT2A 1629/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.